8432.TWO tsh biopharmoration Ltd

Healthcare Pharmaceuticals Taiwan OTC Exchange
58.70 TWD
Close of Nov 6, 2026
48.60 62.20
Market cap
TWD 2.25B
P/E
13.5x
P/B
1.64x
ROE
12.0%
Dividend yield
3.61%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 8432.TWO undervalued?

Graham number
Price58.70
Graham value59.11
Discount0.7%

8432.TWO trades 0.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

tsh biopharmoration Ltd fundamental analysis

No fundamental analysis for tsh biopharmoration Ltd yet.

tsh biopharmoration Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About tsh biopharmoration Ltd

TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan. The company offers prescription medication for cardiovascular, central nervous, gastrointestinal, and others. It also provides MPap, a methylation-specific qPCR technology to detect the methylation status of CDO1 and BHLHE22 genes using cervical scraping; AlphaLiquid Detect, a hybrid capture NGS-based liquid biopsy test designed for MRD detection and surveillance in stage I-III solid tum…

Full company profile